A carregar...
Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine
OBJECTIVE: To assess long‐term (up to 2 years) efficacy, tolerability, and safety of erenumab for the prevention of episodic migraine (EM) in Japanese patients. BACKGROUND: Previously published results from the double‐blind treatment phase (DBTP) of a phase 2 clinical study have demonstrated the eff...
Na minha lista:
| Publicado no: | Headache |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8251924/ https://ncbi.nlm.nih.gov/pubmed/33764538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|